Todd C. Brady
Overview
Todd C. Brady received an average of $3M in total compensation, including $508K in salary, at Aldeyra Therapeutics from 2015 to 2023.
2023Aldeyra TherapeuticsPresident and Chief Executive Officer
2022Aldeyra TherapeuticsPresident and Chief Executive Officer
2021Aldeyra TherapeuticsPresident and Chief Executive Officer
2020Aldeyra TherapeuticsPresident and Chief Executive Officer
2019Aldeyra TherapeuticsPresident and Chief Executive Officer
2018Aldeyra TherapeuticsPresident and Chief Executive Officer
2017Aldeyra TherapeuticsPresident and Chief Executive Officer
2016Aldeyra TherapeuticsPresident and Chief Executive Officer
2015Aldeyra TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on April 22, 2024, May 23, 2023, April 25, 2022, April 27, 2020, April 22, 2019, April 25, 2018, and April 24, 2017.
Related executives
We found seven more executives who work or worked at Aldeyra Therapeutics.
Stephen Machatha
Aldeyra Therapeutics
Chief Development Officer
Bruce Greenberg
Aldeyra Therapeutics
Chief Financial Officer
Joshua Reed
Aldeyra Therapeutics
Chief Financial Officer
David Clark
Aldeyra Therapeutics
Chief Medical Officer
David McMullin
Aldeyra Therapeutics
Chief Commercial Officer
Stephen Tulipano
Aldeyra Therapeutics
Chief Financial Officer
Scott Young
Aldeyra Therapeutics
Chief Operating Officer
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019